Computational studies of TGF-βRI (ALK-5) inhibitors: analysis of the binding interactions between ligand-receptor...

Area of Science:

• Medicinal Chemistry
• Computational Biology
• Molecular Pharmacology

Background:

• Activin-Like Kinase 5 (ALK-5) is a key receptor in pathological processes like cancer and fibrosis.
• ALK-5 signaling influences gene transcription through nuclear protein complexes.
• Developing potent and selective ALK-5 inhibitors is crucial for therapeutic intervention.

Purpose of the Study:

• To develop and validate quantitative structure-activity relationship (QSAR) models for ALK-5 inhibitors.
• To utilize CoMFA and HQSAR methods for predicting inhibitor potency.
• To guide the rational design of novel ALK-5 targeting ligands.

Main Methods:

• Comparative Molecular Field Analysis (CoMFA) was applied to a series of ALK-5 inhibitors.
• Hologram Quantitative Structure-Activity Relationship (HQSAR) was employed for 2D-based modeling.
• Statistical validation of models using correlation coefficients (r^2 and q^2) and prediction on a test set.

Main Results:

• High statistical significance was achieved for both CoMFA (r^2=0.99, q^2=0.85) and HQSAR (r^2=0.92, q^2=0.72) models.
• The developed QSAR models demonstrated strong predictive ability for unseen ALK-5 inhibitor compounds.
• Predicted potencies from both models showed good agreement with experimental data.

Conclusions:

• Validated 2D and 3D QSAR models provide a reliable framework for ALK-5 inhibitor discovery.
• 3D contour maps and 2D contribution maps offer insights into structure-activity relationships.
• These findings facilitate the design of novel, potent, and effective ALK-5 inhibitors for therapeutic applications.